Dexamethasone and T-cell lymphoma refractory - a phase IV clinical study of FDA data

Summary:

T-cell lymphoma refractory is reported as a side effect among people who take Dexamethasone (dexamethasone), especially for people who are female, 30-39 old, also take Etoposide, and have Angiocentric lymphoma.

The phase IV clinical study analyzes which people have T-cell lymphoma refractory when taking Dexamethasone. It is created by eHealthMe based on reports of 161,257 people who have side effects when taking Dexamethasone from the FDA, and is updated regularly.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 161,927 Dexamethasone users. Check the latest studies of Dexamethasone.

What is T-cell lymphoma refractory?

T-cell lymphoma refractory (a t cell cancer resistant to treatment) is found to be associated with 10 drugs and 25 conditions by eHealthMe. Check the latest studies of T-cell lymphoma refractory.

On Jul, 05, 2026

161,257 people reported to have side effects when taking Dexamethasone.
Among them, 19 people (0.01%) have T-cell lymphoma refractory.

$Could Dexamethasone cause T-cell lymphoma refractory?$

Among these 19 people:

What is the gender of people who have T-cell lymphoma refractory when taking Dexamethasone? *

female: 68.75 %
male: 31.25 %

What is the age of people who have T-cell lymphoma refractory when taking Dexamethasone? *

What are other drugs people take besides Dexamethasone? *

What are other side effects people have besides T-cell lymphoma refractory? *

Second Primary Malignancy (after getting cure a cancer, a new cancer development): 8 people, 42.11%
Haematotoxicity (toxins that destroy red blood cells): 5 people, 26.32%
Gastrointestinal Toxicity (damage to digestive tract by any substance): 5 people, 26.32%
Infection: 5 people, 26.32%
Drug Ineffective: 4 people, 21.05%
Hepatomegaly (abnormal enlargement of the liver): 4 people, 21.05%
Acute Kidney Failure: 2 people, 10.53%
Polyomavirus-Associated Nephropathy (polyomavirus-associated kidney disease): 2 people, 10.53%
Fever: 2 people, 10.53%
Dyspnea (difficult or laboured breathing): 2 people, 10.53%

What are the existing conditions these people have? *

Angiocentric Lymphoma (extra nodal natural killer cell cancer): 16 people, 84.21%
Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 21.05%
Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and have T-cell lymphoma refractory?

- Check whether T-cell lymphoma refractory is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dexamethasone:

Dexamethasone (161,927 reports)

Browse all side effects of Dexamethasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with T-cell lymphoma refractory:

T-cell lymphoma refractory (10 drugs)

Browse all the conditions that are associated with T-cell lymphoma refractory:

T-cell lymphoma refractory (25 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Dexamethasone) and Dexamethasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.